Rhinitis patients. Vasomotor and allergic rhinitis and Chronic rhinitis, nasopharyngitis and pharyngitis
Conditions
Interventions
Drug administration:
Fexofenadine: 1 tablet/ day
Fluticasone propionate: one puff nasal spray into each nostril/ day.
Treatment - Drugs
Drug administration:
Fexofenadine: 1 tablet/ day
Fluticasone propionate: one puff nasal spray into each nostril/ day
Sponsors
Vice Chancellor for Research and Technology, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1- People enter to the study should be at the age of 18 to 60 years, 2- They have to study and signature the testimonial before entrance to the study, 3- lack of abnormality in nasal anatomy, 4- having rhinitis symptoms which is confirmed by specialist physician, 5- not being suffered from: asthma, infectious disease, underlying diseases such as diabetes and chronic inflammatory diseases, 6- In addition, pregnant women, people above 65 and those people who suffer from rhinitis because of Senility will not enter the study. Exclusion criteria: 1- People suffering from infectious diseases or common cold during the period of study, 2- patients taking drugs other than drugs that must consume according to the research plan, during Performance of the project, 3- patients who have a fungal, viral or bacterial disease during the t curse of study, 4- patients who do not follow the recommended instructions. All these people will be excluded from the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RORgt. Timepoint: Befor treatment and one month After treatment. Method of measurement: Relative expression of RORgt gene measured by Real-time PCR.;GATA3. Timepoint: Befor treatment and After one month treatment. Method of measurement: Relative expression of GATA3 gene measured by Real-time PCR.;FOXP3. Timepoint: Befor treatment and one month After treatment. Method of measurement: Relative expression of FOXP3 gene measured by Real-time PCR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Gorgin Karaji
School of Medicine, Kermanshah University of Medical Sciences
Outcome results
None listed